Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Diane E Wallis"'
Autor:
Sue Penckofer, Mary Byrn, William Adams, Mary Ann Emanuele, Patricia Mumby, Joanne Kouba, Diane E. Wallis
Publikováno v:
Journal of Diabetes Research, Vol 2017 (2017)
Objective. The aim of this study was to determine the effect of vitamin D supplementation on improving mood (depression and anxiety) and health status (mental and physical) in women with type 2 diabetes mellitus (T2DM). Methods. Fifty women with T2DM
Externí odkaz:
https://doaj.org/article/f3160b37543f4776a19bdd5bda992b68
Autor:
Mary Byrn, Patricia B. Mumby, William Adams, Sue Penckofer, Diane E. Wallis, Joanne Kouba, Mary Ann Emanuele
Publikováno v:
Journal of Diabetes Research
Journal of Diabetes Research, Vol 2017 (2017)
Journal of Diabetes Research, Vol 2017 (2017)
Objective. The aim of this study was to determine the effect of vitamin D supplementation on improving mood (depression and anxiety) and health status (mental and physical) in women with type 2 diabetes mellitus (T2DM). Methods. Fifty women with T2DM
Publikováno v:
The Diabetes Educator. 34:939-954
Diabetes is a leading cause of cardiovascular disease. Persons with diabetes are at greater risk for early cardiac mortality, and for repeat events if they survive their first cardiac event. Recently, low serum concentrations of vitamin D have been a
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 13:353-361
Heparin-induced thrombocytopenia (HIT) is a prothrombotic, immune-mediated adverse reaction to heparin therapy. To evaluate clinical outcomes and effects of argatroban therapy in acutely ill HIT patients. Retrospective analysis. Hospital in-patient.
Publikováno v:
Chest. 129:1407-1416
We investigated the effects of the direct thrombin inhibitor argatroban, patient demographics, and the platelet count on thrombotic risks in heparin-induced thrombocytopenia (HIT), a serious thrombotic condition, to determine if argatroban provides e
Publikováno v:
Chest. 116:1333-1338
Venous limb gangrene has been reported to occur after high warfarin doses in heparin-induced thrombocytopenia (HIT), and this observation has been used to exclude warfarin management in this condition. The outcome of patients receiving modest doses o
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 5:S16-S20
Heparin-induced thrombocytopenia is one of the most difficult problems facing clinicians today. Despite recent understanding of the pathophysiology of this disorder, there are many unresolved issues about diagnosis, prevention, and treatment. In this
Autor:
J. Fareed, Bruce E. Lewis, Fred Leya, Walter Jeske, Diane E. Wallis, Mamdouh Bakhos, Jeanine M. Walenga
Publikováno v:
Hämostaseologie. 19:128-133
SummaryDespite the use of potent anticoagulants such as r-hirudin and argatroban, the morbidity and mortality in heparin-induced thrombocytopenia (HIT) patients remains unacceptable. Data from our in vitro investigations show that thrombin inhibitors
Publikováno v:
The American Journal of Medicine. 106:629-635
PURPOSE: The complications of heparin-induced thrombocytopenia include thrombosis and death. The purpose of the study was to determine whether early heparin cessation can prevent these outcomes. SUBJECTS AND METHODS: We performed a retrospective anal
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 4:160-163